QQ客服 官方微博 反馈留言

	The Efficacy and Safety of Shen Guo Lao Nian Granule for Common Cold of Qi-Deficiency Syndrome: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase II Clinical Trial
	Liu, Xuemei[1]; Fu, Juanjuan[1]; Fan, Tao[1]; Liu, Wei[1]; Jiang, Hongli[1]; Zhang, Ruiming[1]; Ding, Hong[2]; Yang, Haimiao[3]; Hu, Siyuan[4]; Huang, Yuhong[5]
	2017
URL标识	查看原文
WOS记录号	WOS:000412146700001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4718323
专题	成都中医药大学
作者单位	1.[1]Sichuan Univ, West China Hosp, Dept Integrated Tradit & Western Med, Chengdu 610041, Sichuan, Peoples R China 2.[2]Chengdu Univ Tradit Chinese Med, Affiliated Hosp, Dept Natl Good Clin Practice, Chengdu 610041, Sichuan, Peoples R China 3.[3]Changchun Univ Tradit Chinese Med, Affiliated Hosp, Dept Resp Med, Changchun 130051, Jilin, Peoples R China 4.[4]Tianjin Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Good Clin Practice, Tianjin 300193, Peoples R China 5.[5]Tianjin Univ Tradit ChineseMedicine, Affiliated Hosp 2, Ctr Good Clin Practice, Tianjin 300150, Peoples R China 6.[6]Tradit Chinese Med Chengdu Univ, Coll Acupuncture & Tuina, Chengdu 610041, Sichuan, Peoples R China
推荐引用方式 GB/T 7714	Liu, Xuemei[1],Fu, Juanjuan[1],Fan, Tao[1],et al. The Efficacy and Safety of Shen Guo Lao Nian Granule for Common Cold of Qi-Deficiency Syndrome: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase II Clinical Trial[J],2017.
APA	Liu, Xuemei[1].,Fu, Juanjuan[1].,Fan, Tao[1].,Liu, Wei[1].,Jiang, Hongli[1].,...&Mao, Bing[1].(2017).The Efficacy and Safety of Shen Guo Lao Nian Granule for Common Cold of Qi-Deficiency Syndrome: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase II Clinical Trial..
MLA	Liu, Xuemei[1],et al."The Efficacy and Safety of Shen Guo Lao Nian Granule for Common Cold of Qi-Deficiency Syndrome: Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase II Clinical Trial".(2017).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。